Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMEM214 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | RAPGEF1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | GNL3L | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | YIF1A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | IKBKB | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | CLEC11A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | LRP12 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
mRNA | TMEM266 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | FH | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | DAND5 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |